Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rexall Sundown

This article was originally published in The Tan Sheet

Executive Summary

Metab-O-Lite ephedrine-containing weight loss line extended with bars and two ready-to-drink beverages, one milk-based and one carbonated. The products will begin shipping in November, in time for the post-holiday diet season. Cal Sure, with a patented form of calcium (500 mg) as well as 200 IU of vitamin D, will be backed by "full marketing support," the firm says. The calcium form was licensed from the Dutch firm Royal Numico prior to its acquisition of Rexall (1"The Tan Sheet" May 8, p. 3)

You may also be interested in...



Royal Numico/Rexall Sundown Eyes Private Label As Key Growth Area

Combined Royal Numico/Rexall Sundown operations regard their potential for private label sales in the U.S. mass market to be "very high," the firms reported during a May 1 teleconference. Numico and Rexall have little presence in U.S. private label now but appear to be pondering it for the future despite the traditional low margins of the products.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS091417

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel